Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

NCT04078737 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT04078737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04078737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 3
Overall status
Completed
Start date
September 23, 2019
Completion date
July 1, 2021
Enrollment
6,412 (actual)
Sites
214

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, transient ischemic attack